Front. Physiol. Frontiers in Physiology Front. Physiol. 1664-042X Frontiers Media S.A. 10.3389/fphys.2018.00094 Physiology Hypothesis and Theory Toward a Reasoned Classification of Diseases Using Physico-Chemical Based Phenotypes Schwartz Laurent 1 * Lafitte Olivier 2 da Veiga Moreira Jorgelindo 3 1Assistance Publique des Hôpitaux de Paris, Paris, France 2LAGA, UMR 7539, Paris 13 University, Sorbonne Paris Cité, Villetaneuse, France 3Interfaces, Paris-Saclay University, Palaiseau, France

Edited by: Rosalba Parenti, Università degli Studi di Catania, Italy

Reviewed by: Massimiliano Filosto, Asst degli Spedali Civili di Brescia, Italy; Fiona Hollis, University of Lausanne, Switzerland

*Correspondence: Laurent Schwartz dr.laurentschwartz@gmail.com

This article was submitted to Integrative Physiology, a section of the journal Frontiers in Physiology

 28 02 2018 2018 9 94 29 09 2017 29 01 2018 Copyright © 2018 Schwartz, Lafitte and da Veiga Moreira. 2018 Schwartz, Lafitte and da Veiga Moreira

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Background: Diseases and health conditions have been classified according to anatomical site, etiological, and clinical criteria. Physico-chemical mechanisms underlying the biology of diseases, such as the flow of energy through cells and tissues, have been often overlooked in classification systems.

Objective: We propose a conceptual framework toward the development of an energy-oriented classification of diseases, based on the principles of physical chemistry.

Methods: A review of literature on the physical chemistry of biological interactions in a number of diseases is traced from the point of view of the fluid and solid mechanics, electricity, and chemistry.

Results: We found consistent evidence in literature of decreased and/or increased physical and chemical forces intertwined with biological processes of numerous diseases, which allowed the identification of mechanical, electric and chemical phenotypes of diseases.

Discussion: Biological mechanisms of diseases need to be evaluated and integrated into more comprehensive theories that should account with principles of physics and chemistry. A hypothetical model is proposed relating the natural history of diseases to mechanical stress, electric field, and chemical equilibria (ATP) changes. The present perspective toward an innovative disease classification may improve drug-repurposing strategies in the future.

 disease classification physico-chemical forces cell membrane metabolism mitochondria Introduction

Diseases have been historically classified according to their nature, anatomical site, association to an external cause, and the cause of death (Moriyama et al., 2011). The International Classification of Diseases (ICD) provides a health care classification that has been based on these criteria. In its 11th revision, the ICD-11 proposes different dimensions for a given disorder as a function of its topography, temporal properties (acute, chronic), severity, clinical phenotypes (signs and symptoms), and etiology (Jiang et al., 2013). Classification of diseases has excluded the influence of physical and chemical forces governing transformation of energy in both matter and living systems. Energy takes many forms in biological systems. At the cellular level, biological functions are primarily regarded as being influenced by electric, magnetic, light, mechanical, heat, and chemical energies. Heat is cyclically exchanged between cells and environment. Plants, algae, and cyanobacteria absorb light energy via photosynthesis, whereas nuclear forces have only a negligible impact on living systems. Excluding infections, most diseases have unknown etiology, and more or less unclear pathophysiology. In the late 1850s, Louis Pasteur and Robert Koch, put forward the germ theory, according to which diseases are caused by infectious microbes, impairing functioning of structures of different organ systems (Pasteur, 1881). The concept of etiology, or disease's specific causation, was crystallized by the germ theory (Carter, 1980). The physiologist Claude Bernard, Pasteur's contemporary and friend, argued instead for importance of the balance in body internal environment—what he called le milieu intérieur (Bernard, 2013). The other points in his argument are that the physical and chemical sciences provide the foundation for physiology and that biology depends on recognizing that the processes of life are mechanistically determined by physico-chemical forces (Bernard, 1865). Here, we put forward a conceptual framework outlining integrative approaches to classify diseases based on physico-chemical-based phenotypes. These dimensions comprise the same laws that govern inorganic and organic matter.

 Physico-chemical fundamental underpinnings of physiological processes Chemistry governs cellular metabolism

Metabolism is a physico-chemical process which involves the chemical conversion of energy into biological work (Lehninger, 1971). Molecules are absorbed through pores in the membrane and they react to break down molecules to generate energy used in heat formation, which when dissipated maintains body temperature constant and in synthesis of nucleic acids, proteins, and lipids. In a thermodynamic sense, cells can be viewed essentially as an isothermal combustion engine engaged in a Carnot cycle, performing work and generating heat, thus requiring a constant supply of energy-giving molecules like glucose (Fermi, 1956; Lehninger, 1971). Cell metabolism is the sum of all the chemical reactions and dynamic exchanges between a cell and its microenvironment. Utilization of free energy from molecular bond rearrangement of nutrients powers biological processes in every biological organism.

Eukaryote cells, exhibit two opposite metabolisms: catabolic reactions, leading to the breakdown of macromolecules for energetic use and anabolic reactions, which consists of synthesis of biomass. Cells convert energy by means of an electron-proton transfer process to produce ATP. The energy of electron flow is stored under the form of chemical free energy of ATP, which is then used to execute the mechanical, osmotic, and biosynthetic work of cells (Lehninger, 1965, 1971). Metabolic networks continue to generate the requisite amount of energy after removal of certain reactions, characterizing stability and resilience in the face of endogenous and exogenous perturbation (Demetrius, 2013). The standard energy of ATP hydrolysis remains within a narrow range among cells with widely varying membrane potential and mechanisms of energy production (Seyfried and Shelton, 2010; Lane and Martin, 2012). Oxidative phosphorylation (OxPhos) provides about 88% of the total energy and substrate phosphorylation (mainly glycolysis) contributes the remaining 12%. In OxPhos, which occurs within mitochondria, electrical charges are transferred to oxygen via redox reactions and protons are pumped from the matrix across the mitochondrial inner membrane. ATP is synthesized when protons return to the mitochondrial matrix down their electrochemical gradient. The rate of energy production in OxPhos is determined by the conductance of the bio-membrane and the electromotive potential across the membrane (Nicholls et al., 2002). Energy production in glycolysis, however, is independent of electrical gradients. Now, the rate of energy production is determined by the activity of the glycolytic enzymes of the cytoplasm, without exchanging charges with dielectric membranes (Demetrius et al., 2010).

Cell differentiation and proliferation are at least in part controlled by the intracellular pH. Differentiated cells have a lower pH than proliferating cells (Lee et al., 2003). Pouyssegur's group showed that cells cannot proliferate when the intracellular pH is below 7.2 (Sardet et al., 1989). pH change inside cells can be explained by several phenomena, such as the sodium/proton transmembrane exchanger (Moolenaar et al., 1981; Boron, 2004). The intracellular pH plays a key role in determining the way cells allocate energy, especially driving the switch between OxPhos and glycolysis (da Veiga Moreira et al., 2015). At acidic pH, cytoplasmic activity of ATPase is inhibited and mitochondrial respiration is optimal, implicating increased ATP concentrations. On the other hand, when cytoplasmic pH is alkaline, ATP concentration falls, probably due to impaired mitochondrial respiration and increased ATPase activity (Christen et al., 1983). Moreover, it has been demonstrated that intracellular pH drives protein synthesis and DNA replication (Busa et al., 1982; Busa and Crowe, 1983; Hand and Carpenter, 1986). Intracellular acidic pH is followed by global histone deacetylation, leading to chromatin compaction, the phenotype of a dormant cell, like a myocyte or a neuron. Conversely, intracellular pH increase toward alkalinisation is reported to favor acetylation of histone, leading to chromatin decompaction and DNA replication (McBrian et al., 2013; Kurdistani, 2014). These phenomena occur after resting cells are committed to proliferate, such as in cancer. All such chemical equilibria contribute to the chemical driving forces distribution at play in the body.

 Mechanical forces underlie cell biology

The influence of mechanical energy of living organisms is omnipresent. Cells are continuously subjected to stretching, compression, and shear forces that influence cell division, gene expression, cell migration, morphogenesis, cell adhesion, fluid homeostasis, ion channel gating, and vesicular transport (Hamill and Martinac, 2001; Kim et al., 2009; Eyckmans et al., 2011). The seminal work of D'Arcy Thompson demonstrated that mechanical forces play a key role in plant and animal morphogenesis (Thompson, 1942). These physical forces displace the relative locations of molecules within cells and tissues, which give rise to viscoelastic deformation of membranes and cytoskeletal and extracellular matrices (Eyckmans et al., 2011). We already have an intuitive understanding of the distribution of mechanical forces when we consider pressure, which depends not only on environmental and endogenous loads (pressure exerted by cavities and blood) but also on intrinsic mechanical factors of organs, such as shape, architecture, and mechanical properties of tissues (Brinckmann et al., 2002; Jacobs et al., 2012; Levy Nogueira et al., 2016).

Fluid mechanics can influence cell function via osmotic pressure. This form of pressure is exerted when water is transported across a semi-permeable membrane, a membrane allowing only water molecules but none of solute molecules to pass through (DeDuve, 1991). Oncotic pressure is a form of osmotic pressure exerted by proteins, notably albumin, in blood plasma that usually tends to pull water from interstitial, lymphatic and cerebrospinal fluids, into the circulatory system. Enhanced anabolism results into production of dissolved biomass products, hence in increased osmotic and oncotic pressures. It is the opposing force to hydrostatic pressure, generated by the weight of a liquid in presence of gravity. In blood circulation, hydraulic pressure changes with body posture. The hydraulic pressure is due to the external force acting on a surface of a liquid; in blood circulation, the origin of this force is the heart and blood vessels. When a liquid flows, a dynamic pressure is produced in the flow direction and the total pressure in this liquid is the sum of hydrostatic and dynamic pressures. All these forces contribute to the mechanical driving forces distribution at play in the body.

 Electrical forces drive cell membrane functions

Local electric fields within cells result mostly from the distributions of charged particles, such as ions Na+, K+, Ca2+, and Cl− across phospholipid bilayer membranes by the opening and closing of channels. Such distributions result from diffusion and electrostatic forces generated by ion gradients and electrochemical potentials. The first cell studied from the point of view of the electricity was the neuron. The flow of electrical currents through an axon was firstly described by the cable theory, developed in the nineteenth century by Lord Kelvin to explain the flow of electricity in submarine cables. Cole, Goldman, Hodgkin and Katz adapted cable theory in the 1920–40s, considering resistances and capacitances of cells membranes and the properties of electrolytes that surround it (Goldman, 1943; Hodgkin and Huxley, 1952). Later, cable theory, Hodgkin and Huxley model and its modified versions took into account the influence of ion channels and ionic dynamics to study the electrical conduction and excitability of dendrites and neural networks (Butera et al., 1999; Stuart et al., 2016). More recently, synaptic currents have been more accurately described at nanoscale dimensions using the Poisson–Nernst–Planck equation and electro-diffusion modeling (Holcman and Yuste, 2015). Electrical currents propagate along the axon in neuronal networks but also it plays an important role in coordinating the contraction of the heart. Cardiac electrical potentials are generated by the sinoatrial node, the natural pacemaker of the heart and propagate from atria to ventricles via the atrioventricular node. Cardiac and skeletal muscle cell are excitable fiber conductors like neurons. In these cells, action potentials are triggered by arrival of synaptic currents at the neuromuscular junction. Electrical current plays also a key role in cell growth regulation and organogenesis (Pethig and Kell, 1987; Kubota et al., 1995; Thakral et al., 2013). All such electrical interactions contribute to the electric fields distribution at play in the body.

 Physico-chemical-based phenotypes of diseases Diseases exhibiting changes in metabolic rates: chemical phenotypes

Hypermetabolism, an increase in metabolic rate, is a hallmark of sustained pathophysiological stress response observed in fever, burn injury, severe trauma, and systemic inflammatory reaction in critically ill patients (Frankenfield et al., 1997; Porter et al., 2014). The initial description of the effects thyroid hormones on metabolic rate has made more than 100 years ago (Magnus-Levy, 1895). Thyroxin and triiodothyronin hormones, as well as adrenergic drugs, like epinephrine, and amphetamines increase metabolic yield (Nahorski and Rogers, 1973; Fisher et al., 1998; Ratheiser et al., 1998). Inversely, there are multiple mechanisms for decreased metabolic energy yield. The most common is probable age, a key risk factor for most diseases. Decreased metabolic rate may be due to lack of nutrients, such as in malnutrition, ischemia or anemia; or associated to some endocrine diseases like type 1 diabetes and hypothyroidism (Charlton and Nair, 1998; Singhal et al., 2002; Emery, 2005; McAninch and Bianco, 2016).

As stated by Otto Warburg almost 90 years ago, cancer is the simple consequence of altered metabolism (Warburg, 1956). In cancer cells, there is an increased uptake of glucose to compensate for the decrease energy yield, itself a consequence of a decreased mitochondrial activity. The pyruvate cannot be degraded via the Krebs cycle because the number of mitochondria is reduced (Levine and Puzio-Kuter, 2010; Schwartz et al., 2010; Israël and Schwartz, 2011; Porporato et al., 2011; Abolhassani et al., 2012). The mitochondrial defect results in decreased CO2 synthesis and alkalinization of the cytoplasm. A consequence of decreased mitochondrial activity is activation of the Pentose Pathway and tumor growth (Israël and Schwartz, 2011). In cancer, metabolic fluxes are diverted toward the pentose phosphate shunt rather than OxPhos, due to Warburg effect. Activation of this pathway results in synthesis of DNA and RNA (Levine and Puzio-Kuter, 2010; Schwartz et al., 2010; Israël and Schwartz, 2011; Porporato et al., 2011; Abolhassani et al., 2012). In cancer cells, the fuel is glucose and mitochondria do not secrete enough CO2 to acidify the cytoplasm. Therefore, the cytoplasm of the cancer cell is alkaline.

Mitochondrial dysfunction has been reported in numerous brain diseases—to name a few: Alzheimer's disease (AD) (Moreira et al., 2007), Parkinson's disease (Narendra et al., 2009), Huntington disease (Beal, 2005), bipolar disorders and schizophrenia (Clay et al., 2011). In AD, mitochondrial instability and dysfunction appear in a distinct population of neurons (Hirai et al., 2001). In order to sustain their energy needs, these neurons will disproportionally up-regulate OxPhos and consume more fuel substrates (lactate) (Demetrius and Driver, 2013). More vulnerable neurons, such as those from entorhinal cortex and hippocampus, could be damaged in consequence of glucose and lactate shortage. Circumscribed hypometabolism over these areas can be visualized in early stages of the disease of the brain [18F]fluorodeoxyglucose PET (FDG-PET) (Yakushev et al., 2011). This mode of neuroenergetic reprogramming is called the inverse Warburg effect (Demetrius et al., 2014). Inversely to cancer, the cytoplasm of brain cell in AD patients has an acidic pH in consequence of accumulation of lactic acid (Fang et al., 2010; Demetrius and Driver, 2013). Alkaline cytoplasm is strongly mitogenic, while acidic pH results in cell death (Zetterberg and Engström, 1981; Gottlieb et al., 1996).

 Diseases exhibiting changes in mechanical forces: mechanical phenotypes

During an acute inflammatory reaction, extravasation of plasma proteins occurs from the intravascular to the interstitial space (Table 1). For diagnostic proposes, clinicians currently identify high concentrations of protein in inflammatory fluids, such as in pleural effusion or pericarditis. This high protein content results in increased osmotic and colloid pressure. We have previously shown both in vivo and in vitro that hyperosmolarity can induce proinflammatory cytokine responses in epithelial cells (Abolhassani et al., 2008; Schwartz et al., 2008, 2009). Our group and others recently demonstrated that inflammation results from increased interstitial pressure (Grimble, 2003; Abolhassani et al., 2008; Schwartz et al., 2008, 2009). Osmotic forces have been linked to conditions like Crohn's disease, or ulcerative colitis (Schilli et al., 1982), ascites (Runyon, 1994), pericarditis (Szturmowicz et al., 1997), atherosclerosis (Blake and Ridker, 2002), arthritis (Sipe, 1995), pneumonia (Montón and Torres, 1998), and glaucoma (Flammer et al., 2002). The increased interstitial pressure may be responsible for common features of fibrosis and cancer. Increased fluid pressure is known to induce collagen deposition and modulate cell proliferation either by cell death or by cell multiplication (Schwartz et al., 2002). Cancer invades preferentially soft tissues such as glands or muscle rather than fascia or bone (Schwartz, 2004). Changes in physical constraints explain the stellar dendritic shape of cancer, enabling cells to escape physical constraints from their neighbors (Schwartz et al., 2002; Fleury and Schwartz, 2003). This functional polarity is most often lost during carcinogenesis (Locke, 1998).

Mechanical phenotypes of diseases.

Mechanical phenotype system Decreased (insufficient) Increased (accumulation of) Tensile, compressive shear forces (Solid mechanics) Hydrostatic hydrodynamic, osmotic and oncotic forces (Fluid mechanics)
Osteomuscular Osteopenia, osteoporosis (Bloomfield et al., 2016)**Muscle atrophy (Bloomfield et al., 2016) - Due to long-duration bed rest, microgravity, limb paralysis or insufficient physical activity Bone fracture (Mirzaali et al., 2015)Muscle and tendon rupture (Neviaser et al., 2012)Disk herniation (Gregory and Callaghan, 2010)Osteoarthritis (Silver and Bradica, 2002; Abramson and Attur, 2009; Vincent et al., 2012; Visser et al., 2014) Silver and Bradica, 2002; Gregory and Callaghan, 2010; Neviaser et al., 2012; Vincent et al., 2012; Visser et al., 2014; Mirzaali et al., 2015; Bloomfield et al., 2016 Abramson and Attur, 2009
Cardiovascular Orthostatic hypotension (Eiken et al., 2008)Hypovolemia, hypoperfusion (Kreimeier, 2000)Hypoxia, ischemia (Rumsey et al., 1994)Space Obstructive Syndrome (Wiener, 2012) Arterial hypertension (Safar et al., 2003)Aneurysm and arterial dissection (Numata et al., 2016)Atherosclerosis (Anwar et al., 2012)Plaque rupture (De Korte et al., 2016)Cardiomyopathy (Modesto and Sengupta, 2014) Kreimeier, 2000; Eiken et al., 2008; Anwar et al., 2012; Wiener, 2012; Modesto and Sengupta, 2014 Rumsey et al., 1994; Kreimeier, 2000; Safar et al., 2003; Eiken et al., 2008 Anwar et al., 2012; Modesto and Sengupta, 2014; De Korte et al., 2016; Numata et al., 2016
Respiratory Hypoxic respiratory failure (Henderson and Sheel, 2012)High-altitude pulmonary edema (Swenson et al., 2002)Chronic Mountain Sickness (Villafuerte and Corante, 2016)Restrictive syndrome due to neuromuscular disorders (Celli, 2002) Pulmonary hypertension (Puwanant et al., 2010)Pulmonary congestion (Picano and Pellikka, 2016)Chronic obstructive pulmonary disease (Bidan et al., 2015)Surfactant dysfunction (Douville et al., 2011) Puwanant et al., 2010; Henderson and Sheel, 2012; Bidan et al., 2015; Villafuerte and Corante, 2016 Douville et al., 2011 Celli, 2002; Swenson et al., 2002; Puwanant et al., 2010; Douville et al., 2011; Henderson and Sheel, 2012; Bidan et al., 2015; Picano and Pellikka, 2016; Villafuerte and Corante, 2016
Digestive Gastroesophageal reflux disease (Diamant, 2006; Pandolfino et al., 2010)Hiatus hernia (Diamant, 2006; Pandolfino et al., 2010) Cirrhosis (Schwartz, 2014)Portal hypertension (Zhang et al., 2008) Diamant, 2006; Zhang et al., 2008; Pandolfino et al., 2010 Zhang et al., 2008; Schwartz, 2014
Nervous Spontaneous intracranial hypotension (Hasiloglu et al., 2012)High-altitude cerebral edema (Imray, 2016)High-altitude and microgravity headache (Wilson et al., 2011)Post-lumbar puncture headache and brain herniation (Kongstad and Grände, 1999) Adult chronic hydrocephalus (Orešković and Klarica, 2011)Chronic traumatic encephalopathy (McKee et al., 2013; Stein et al., 2014)Alzheimer's diseases (Levy Nogueira et al., 2015a,b)Parkinson's disease (Goldman et al., 2006)Amyotrophic lateral sclerosis (Pupillo et al., 2012)Noise-induced hearing loss (Sun et al., 2015) Goldman et al., 2006; Wilson et al., 2011; Levy Nogueira et al., 2015a,b Kongstad and Grände, 1999; McKee et al., 2013; Stein et al., 2014 Pupillo et al., 2012; Sun et al., 2015 Kongstad and Grände, 1999; Wilson et al., 2011; Hasiloglu et al., 2012; Imray, 2016 Orešković and Klarica, 2011; Sun et al., 2015
Systemic conditions Fluid shifts * (Bloomfield et al., 2016; Johnson and Luks, 2016)Soft tissue changes due to microgravity (Avula, 1994) Fluid shifts* (Bloomfield et al., 2016; Johnson and Luks, 2016)Soft tissue damage due to traumatic and non-traumatic loads (Shoham and Gefen, 2012; Valdez and Balachandran, 2013)End-organ damage due to blood pressure (Safar et al., 2012) Inflammation (Abolhassani et al., 2008; Schwartz et al., 2008; Levy Nogueira et al., 2016)Cancer (Schwartz et al., 2002; Schwartz, 2004; Levy Nogueira et al., 2016) Avula, 1994; Schwartz et al., 2002; Schwartz, 2004; Abolhassani et al., 2008; Safar et al., 2012; Shoham and Gefen, 2012; Valdez and Balachandran, 2013; Bloomfield et al., 2016; Johnson and Luks, 2016; Levy Nogueira et al., 2016 Schwartz et al., 2002, 2008; Schwartz, 2004; Safar et al., 2012; Levy Nogueira et al., 2016

Fluid shifts: edema, ascites, pleural, pericardial and joint effusion.

Numbers in square are the related references.

Fluid mechanical constraints can also be caused by hemodynamic stress. Hydrodynamic forces acting on vessel walls include shear stress generated by blood flow and circumferential stress resulting from blood pressure. Morphological and molecular changes in blood vessels ascribed to elevated pressure consist of endothelial damage, neointima formation, activation of inflammatory cascades, uptake of atherogenic lipoproteins, hypertrophy, migration and changes in vascular smooth muscle cells, as well as extracellular matrix imbalances (Cunningham and Gotlieb, 2005; Anwar et al., 2012). The exact mechanism of converting shear energy into biochemical signal is not yet well understood. The strain in atherosclerotic plaques due to the pulsatile pressure is highly correlated to plaque rupture and thus an ischemic event (De Korte et al., 2016). Hemodynamic stress also induces cardiac valve disease (Robicsek and Thubrikar, 2002), ventricular hypertrophy (Neeland et al., 2013), pulmonary hypertension (Puwanant et al., 2010), brain lacunar infarcts, microbleeds, and white matter hyperintensities (Saji et al., 2016), as well as glomerulopathy (Gnudi et al., 2003).

Chronic adult hydrocephalus is characterized by an excessive enlargement of the brain ventricles, which leads to parenchymal shrinkage. It is most commonly accepted that continuous or transient cerebrospinal fluid hypertension leads to chronic hydrodynamic stress on ventricular walls, ultimately resulting in ventricular dilatation (Streitberger et al., 2011). Hemodynamic stress has also associated with migraine (van Alphen, 1986; Gudmundsson et al., 2006). Epidemiological, neuropathological, microstructural studies largely support the notion that mechanical stress triggers and/or accelerates neurodegenerative diseases, including AD, Parkinson' disease and amyotrophic lateral sclerosis. Hemodynamic and hydrodynamic factors, such as hypertension and chronic adult hydrocephalus, and exposition to traumatic brain injury consists on well-established risk factors for AD (Plassman et al., 2000; Schmidt et al., 2001; Goldman et al., 2006; Uryu et al., 2007; Johnson et al., 2012; Levy Nogueira et al., 2016). Finally, energy storage and dissipation, explained by the laws of solid mechanics, are related to possible mechanisms of changes in cartilage structure and function that occur in osteoarthritis (Silver and Bradica, 2002; Vincent et al., 2012; Visser et al., 2014).

 Diseases exhibiting changes in electrical features: electric phenotypes

Depression and neurodegenerative disorders are characterized by reduced electrical brain excitability (Concerto et al., 2013; Ni and Chen, 2015) (Table 2). For this reason, numerous studies have addressed short-term and long-term effects of transcranial direct current stimulation (tDCS) (Meinzer et al., 2014), transcranial magnetic stimulation (TMS) (Jay et al., 2016), electroconvulsive therapy (ECT), and deep brain stimulation (DBS) on these affections (Kumar et al., 1998). Bradyarrhythmias could also be classified as diseases with reduced electrical currents (Song et al., 2012). They have been classically treated by cardiac pacemaker stimulation. Epilepsy (Reynolds, 2001), restless legs syndrome (Bara-Jimenez et al., 2000), pain disorders (Theuvenet et al., 1999), bipolar disorder (Mertens et al., 2015), essential tremor (Louis, 2014), cardiac tachyarrhythmias (Li et al., 2009) (e.g., atrial fibrillation, flutter) are diseases characterized by electrical hyperexcitability. They have been treated by drugs that modulate ion channels, such as antiepileptic drugs, benzodiazepines and antiarrhythmic agents (Katzung et al., 2015). They target transmembrane channels modulating transmembrane currents.

Electric phenotypes of diseases.

Electrical phenotype Decreased Increased Electrical forces, energy, potentials, currents, discharges, excitability
Skeletal muscle and nerve MyopathiesNeuropathiesChannelopathiesMyasthenia gravis Muscle spasticity, tetany and reinnervationNeuropathic pain Gutmann and Gutmann, 1996; Theuvenet et al., 1999; Preston and Shapiro, 2012; Sheean, 2012; Abraham et al., 2016
Cardiac muscle Bradyarrhythmias Tachyarrhythmias (flutter, atrial fibrillation) Li et al., 2009; Song et al., 2012
Brain and spinal cord DepressionNeurodegenerative diseasesComa and brain death Bipolar disorderRestless legs syndromeEpilepsyEssential tremor Bara-Jimenez et al., 2000; Concerto et al., 2013; Mertens et al., 2015; Ni and Chen, 2015 Reynolds, 2001; Louis, 2014
Cancer Mitochondrial dysfunction (Warburg effect) Pokorný et al., 2014
Therapies Drugs: antiepileptics, neuroleptics benzodiazepines, anesthetics, muscle relaxants, antiarrhythmics Transcranial direct current stimulation (tDCS)Transcranial magnetic stimulation (TMS)Deep brain stimulation (DBS)Electroconvulsive therapy (ECT) Kumar et al., 1998; Meinzer et al., 2014; Katzung et al., 2015; Jay et al., 2016
Thermodynamic phenotypes of cancer

In the case of cancer there is concomitant increased pressure and decreased electromagnetic fields. During hepatic biopsy, the interstitial pressure of the hepatic parenchyma was measured. About 17–19 gauge guiding needle was advanced to the tumor under CT guidance (Schwartz, 2014). The pressure of the normal liver parenchyma is 4 mm Hg. It raises to 13 in premalignant cirrhosis. The pressure of primary liver cancer was between 25 and 26 mm Hg. The increased pressure may be a direct consequence of impaired mitochondrial activity such as described by Otto Warburg (Schwartz et al., 2017) (Table 3).

Thermodynamic phenotypes of the diseases.

Thermodynamic phenotype Decreased Increased Metabolic rate
Lifespan Aging Childhood Demetrius et al., 2014
Consciousness level Sleep, delirium, torpor, coma Wakefulness Staples, 2016
Physical activity Rest Exercise
Systemic conditions HypothyroidismMetabolic syndromeMalnutritionAnemiaIschemiaDrugs: beta blockers HyperthyroidismFeverBurn injuryDrugs: thyroid hormones, metformin, epinephrine and other adrenergic agonists Magnus-Levy, 1895; Nahorski and Rogers, 1973; Fisher et al., 1998; Ratheiser et al., 1998; Singhal et al., 2002; Emery, 2005; Porter et al., 2014
Cancer Mitochondrial OxPhos*-Therapeutic approach: ↗ mitochondrial OxPhos* -Cytosolic glucose metabolism*-Therapeutic approach: ↘ cytosolic glucose metabolism Warburg, 1956; Levine and Puzio-Kuter, 2010; Schwartz et al., 2010; Israël and Schwartz, 2011; Porporato et al., 2011; Abolhassani et al., 2012
Neuropsychiatric conditions Alzheimer's disease:-Cytosolic glucose metabolism**Parkinson's diseaseHuntington diseaseSchizophrenia Alzheimer's disease:-Mitochondrial OxPhos**EpilepsyDrugs: amphetamines Hirai et al., 2001; Beal, 2005; Moreira et al., 2007; Narendra et al., 2009; Clay et al., 2011 Yakushev et al., 2011; Demetrius and Driver, 2013; Demetrius et al., 2014

Warburg effect,

Inverse Warburg effect, ↗ stimulate, ↙inhibit. OxPhos, oxidative phosphorylation.

 Mechanical, electric, and chemical phenotypes are intertwined

The different forms of energy are interconvertible, following James Joule's discovery (Joule, 1843). The first law of thermodynamics is a statement regarding the conservation of energy: although energy can be converted from one form to another, the total energy of a closed isolated system is constant. Inorganic as well as living organisms are following the rules of thermodynamics. They are most of the time in a non-equilibrium state, but are very often in a stationary state. But in general for local analysis (in the order of cell size) or for stationary state one may describe their behavior as a near-equilibrium system, using therefore equilibrium thermodynamics variables. Diseases could be explained by their departure from a homeostatic stationary state (Demetrius, 2013). Consequently, mechanical, electric and chemical energies are intertwined in metabolism of living organisms. As stated before, cancer is related to increased interstitial and intracellular pressure and decreased chemical rate of ATP formation within mitochondria (Warburg effect). Inflammation is also linked to increased osmotic pressure, a way to translate chemical gradients into pseudo-mechanical driving forces, and a transient Warburg effect, a partial and reversible inhibition of mitochondrial activity (Srivastava and Mannam, 2015; Aounallah et al., 2016). In both cancer and inflammation situations, energy is redirected from oxidative phosphorylation (mitochondria) to the pentose phosphate pathway (cytosol), increasing biomass synthesis and, theoretically, intracellular osmotic pressure and colloid pressure (aka oncotic pressure, a special osmotic pressure due to the presence of colloidal proteins in the blood plasma).

The effect of mechanical forces on mitochondrion has been poorly studied. This organelle is composed essentially of soft bilayer membranes and many of its functions involve the manipulation of its curvature, as it is easy to sustain curvature strains in a membrane due to its high elasticity (Kumar et al., 1998). Differences in tension between the two membrane interfaces can create changes in curvature with the displacement of lipids, channels, and pumps. As a consequence, the resultant of the electrical forces across curved membranes can change (Petrov, 2006). This phenomenon is called flexoelectric effect (Petrov, 2002, 2006) and it explains, for example, how mechanosensing organelles of hair cells respond to the fluid motion in the inner ear, converting membrane deformation into electric signals. Conformational changes induced by cytoskeletal tension or osmotic pressure may convert mitochondrion into a non-energized state, impairing electrical currents, but still allowing mitochondrial smooth movements of fission and fusion. The fact that energized mitochondria have inner membranes extensively curved is quite indicative of the role of flexoelectricity in the energy transformation (Hackenbrock, 1968; Harris et al., 1968; Green and Young, 1971). Indeed, thermodynamic laws have predicted that membrane tension modulates transmembrane voltage (Zhang et al., 2001). Figure 1 shows a hypothetical model relating the natural history of diseases to mechanical stress accumulation, electric forces, and chemical energy (ATP).

Hypothetical model relating the natural history of diseases to mechanical stress accumulation coupled to electric forces and free energy (ATP) decline. Intra and extracellular long-term consequences of mechanical stress imply in deformation and/or breakdown of extracellular matrix, cytoskeleton, and membranes (including mitochondria). Consequently, transmembrane plasmatic and mitochondrial electric potentials decline. The metabolic rate of generation of free energy through ATP also declines, due to its dependence to mitochondrial inner membrane integrity. Glycolysis will be abnormally up-regulated (Warburg effect), as it does not depends on mitochondrial membranes. This mode of fermentation generates thermodynamically stable biomass, composed by, for example, phospholipid membranes, nucleic acid (proliferation) and cellular waste aggregates (fibrosis, brain protein deposits).

 Handling the complexity of phenotypes in a single frame

Up to now, single components of phenotypes have been reported, as well as intertwined components. For each category: mechanical, electric, and chemical physico-chemical phenotypes a wide variety of incarnations exists. Each component of a phenotype is characterized by its free energy, and the global system described is a full thermodynamic system. Physico-chemical phenotypes can be extended to any sort of energy containing interaction as is immediately understandable for magnetic or light (electromagnetic) or radiations interactions. MRI, Radiotherapy, laser medicine are common applications of using such means of interactions with physical constraint. Each energy component of a phenotype can involve several intensive parameters. An energy may arise from simultaneous action of two metabolic pathways coupling two chemical reactions. Another may involve pressure and a chemical gradient, etc. For each doubly, triply or most of the time more coupled interactions, a much wider variety of components exist. Would it be therefore possible to combine them in order to profile diseases from the phenotypic point of view? This may be a way to act onto proper variables in order to reprogram them and to restore the homeostatic state.

Biological systems when modeled as physical systems are thermodynamic open systems exhibiting a hierarchical organization. Therefore the global system must be represented by sub-systems that are weakly connected and can each be considered as an open system itself. When in a stationary state, they may be treated as at equilibrium, and the variables to manipulate each sub-system can be those of equilibrium. Therefore, such a frame offers the ability to organize phenotypes by their disease profile, a successful strategy used by Damasio in his research about the structure of the brain called the “human lesion method.” In such a strategy the number of variables modified by the existence of the lesion is much lower than the total number of variables necessary to describe the overall thermodynamic system.

Therefore if a system of objects is to be analyzed, each component or entity like a cell or any relevant organ or organelle is to be thermodynamically described. Its free energy can be described as the sum of the free energy of a standard state plus the sum of all additional free energy components needed to describe their departure from the standard state. Chemical electric and mechanical energies, as well as magnetic and electromagnetic (light) energies, must be considered for each node of the graph of the subsystem. Moving from point approximation for electrons or atoms to molecules or ions, the space extension of larger objects must be take into account. This is done by attaching to each node a shape. Therefore energies that are expressed in their simple point version as product of numbers (ex: charge, voltage) become spatial extensions described by geometrical “tensors.” Point objects are rank 0 tensors, a rod or wire a rank 1 tensor, an ellipsoidal object (spherical cell or oblong cell) a rank 2 tensor and so on. Most of simple products like an electric energy zi.Φi become tensor products {zi}⊗{Φi}. Here a charge tensor and an electric field tensor, each of rank 2. Standard states can be chosen as the stationary states, or homeostatic standard states.

Once this set of axiomatic choice has been made then a disease will be described by all the functional components that are strongly linked leading to a subset of the large system, leaving the weak linkages outside the primary scope of description. The variables attached to the nodes of the graph as well as the graph are the representation of the physico-chemical phenotype of the disease.

In the current state of such “network medicine” formalism the current phenotypes based on non-physico-chemical elements are inadequate (Loscalzo et al., 2007). However, if molecular entities are taken into account it is surprising that physical parameters seem paradoxically to be completely absent from the postgenomic era approach. Electric, magnetic field, T, P have to be added in a thermodynamic system. Furthermore, these physical parameters might not be constant, but variable, as for example a radio-frequency electric or magnetic field. Cellular phones, all sorts of wireless connections, are generating such frequencies and are definitely part of a phenotype. Pressure pulsations are generated by acoustic waves etc. All free energies available for describing the thermodynamic model in phenotypes, not only for assessing the disease but addressing the therapeutical strategies, may contain all sort of physical energy contributions creating much more connections between nodes than the simple molecular genetic or metabolic pathways.

To face such a complexity, hierarchization of the system is mandatory. However this hierarchization must fulfill one essential criterion: phenotypes must be as mentioned earlier at the same time able to group, within a limited number of categories, a large number of diseases and must be usable by practitioners to define a possible strategy for curing the disease. Most of graph theories developed up to now are focused on molecular and genetic approaches giving rise to metabolomics, genomics and other typologies but they are missing several of the critical criteria that could them make usable by the researcher as well as the practitioner. Among the obvious missing pieces of information, physical phenotypic parameters are not considered may be useful for medical doctors in his/her therapeutic guidance.

The purpose of this contribution is to propose another vision of describing diseases by using a set of phenotypes analogous to Mendeleev's table (Table 1). This would give rise to an infinite possibility of combinations with a reasonable small set of phenotypes and to a very large set of rules leading to an infinite number of diseases, analogous to the extremely large scope of chemistry in all its incarnations.

 Conclusion and perspectives

To advance our understanding of the mechanisms of diseases, biological process needs to be evaluated and integrated into more comprehensive and global theories, accounting with principles of physics. The word “physician” is a reminiscence of the time when medicine was a part of Physics. We propose a conceptual framework that outlines integrative approaches to classify diseases based on physics-based phenotypes. Classical diagnostic systems may not capture mechanical, electric and thermodynamic underlying common mechanisms of diseases. Identifying syndromes based on these phenotypes may improve therapeutic outcomes. For example, electrical energy is a treatment for numerous brain disorders via (tDCS) (Meinzer et al., 2014), TMS (Jay et al., 2016), electroconvulsive therapy (ECT), and DBS (Kumar et al., 1998). The present perspective toward an innovative disease classification may also improve drug-repurposing strategies in the future. We recognize that we are still a long way from knowing if this approach will succeed. The physical parameters should be introduced in “omics” studies and especially correlations between parameters governing basic thermodynamic behavior. Such correlations affect many processes at a time, and must be extremely useful to correlate with other metabolic profiling methods.

 Author contributions

LS and OL: elaborated the concept of this article and wrote the article; JdVM: reviewed and wrote the article.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

We wish to acknowledge the major help of Marcel Levy-Nogueira. This paper could not have been written without his help.

 References Abolhassani M. Guais A. Sanders E. Campion F. Fichtner I. Bonte J. . (2012). Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice. Invest. New Drugs 30, 1331–1342. 10.1007/s10637-011-9692-721655919 Abolhassani M. Wertz X. Pooya M. Chaumet-Riffaud P. Guais A. Schwartz L. (2008). Hyperosmolarity causes inflammation through the methylation of protein phosphatase 2A. Inflamm. Res. 57 419–429. 10.1007/s00011-007-7213-018777115 Abraham A. Alabdali M. Alsulaiman A. Breiner A. Barnett C. Katzberg H. D. . (2016). Repetitive nerve stimulation cut-off values for the diagnosis of myasthenia gravis. Muscle Nerve. 55, 166–170. 10.1002/mus.25214 Abramson S. B. Attur M. (2009). Developments in the scientific understanding of osteoarthritis. Arthritis Res. Ther. 11, 227. 10.1186/ar265519519925 Anwar M. A. Shalhoub J. Lim C. S. Gohel M. S. Davies A. H. (2012). The effect of pressure-induced mechanical stretch on vascular wall differential gene expression. J. Vasc. Res. 49, 463–478. 10.1159/00033915122796658 Aounallah M. Dagenais-Lussier X. El-Far M. Mehraj V. Jenabian M. A. van Grevenynghe J. . (2016). Current topics in HIV pathogenesis, part 2: inflammation drives a Warburg-like effect on the metabolism of HIV-infected subjects. Cytokine Growth Factor Rev. 28, 1–10. 10.1016/j.cytogfr.2016.01.00126851985 Avula X. J. (1994). Simulation of gravitational field variation on fluid-filled biological membranes. J. Gravitational Physiol. J. Int. Soc. Gravit. Physiol. 1, P108–P109. 11538733 Bara-Jimenez W. Aksu M. Graham B. Sato S. Hallett M. (2000). Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 54, 1609–1616. 10.1212/WNL.54.8.160910762502 Beal M. F. (2005). Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58, 495–505. 10.1002/ana.2062416178023 Bernard C. (1865). Introduction à L'étude de la Médecine Expérimentale. Paris: J. B. Baillière et fils. Bernard C. (2013). Lecons de Physiologie Experimentale Appliquee a la Medecine, Faites Au College de France. Paris: Hachette Livre - Bnf. Bidan C. M. Veldsink A. C. Meurs H. Gosens R. (2015). Airway and extracellular matrix mechanics in COPD. Front. Physiol. 6:346. 10.3389/fphys.2015.0034626696894 Blake G. J. Ridker P. M. (2002). Inflammatory bio-markers and cardiovascular risk prediction. J. Intern. Med. 252 283–294. 10.1046/j.1365-2796.2002.01019.x12366601 Bloomfield S. A. Martinez D. A. Boudreaux R. D. Mantri A. V. (2016). Microgravity stress: bone and connective tissue. Compr. Physiol. 6, 645–686. 10.1002/cphy.c13002727065165 Boron W. F. (2004). Regulation of intracellular pH. Adv. Physiol. Educ. 28, 160–179. 10.1152/advan.00045.200415545345 Brinckmann P. Frobin W. Leivseth G. (2002). Musculoskeletal Biomechanics. Munster: Thieme. Busa W. B. Crowe J. H. (1983). Intracellular pH regulates transitions between dormancy and development of brine shrimp (Artemia salina) embryos. Science 221, 366–368. 10.1126/science.221.4608.36617798891 Busa W. B. Crowe J. H. Matson G. B. (1982). Intracellular pH and the metabolic status of dormant and developing Artemia embryos. Arch. Biochem. Biophys. 216, 711–718. 10.1016/0003-9861(82)90261-27114857 Butera R. J. Rinzel J. Smith J. C. (1999). Models of respiratory rhythm generation in the pre-Bötzinger complex. I. Bursting pacemaker neurons. J. Neurophysiol. 82, 382–397. 10.1152/jn.1999.82.1.38210400966 Carter K. C. (1980). Germ theory, hysteria, and Freud's early work in psychopathology. Med. Hist. 24, 259–274. 10.1017/S002572730004031X6997653 Celli B. R. (2002). Respiratory management of diaphragm paralysis. Semin. Respir. Crit. Care Med. 23, 275–281. 10.1055/s-2002-3303616088620 Charlton M. R. Nair K. S. (1998). Role of hyperglucagonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate. Diabetes 47, 1748–1756. 10.2337/diabetes.47.11.17489792544 Christen R. Schackmann R. W. Shapiro B. M. (1983). Metabolism of sea urchin sperm. Interrelationships between intracellular pH, ATPase activity, and mitochondrial respiration. J. Biol. Chem. 258, 5392–5399. 6222053 Clay H. B. Sillivan S. Konradi C. (2011). Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 29, 311–324. 10.1016/j.ijdevneu.2010.08.00720833242 Concerto C. Lanza G. Cantone M. Pennisi M. Giordano D. Spampinato C. . (2013). Different patterns of cortical excitability in major depression and vascular depression: a transcranial magnetic stimulation study. BMC Psychiatry 13:300. 10.1186/1471-244X-13-30024206945 Cunningham K. S. Gotlieb A. I. (2005). The role of shear stress in the pathogenesis of atherosclerosis. Lab. Invest. 85, 9–23. 10.1038/labinvest.370021515568038 da Veiga Moreira J. Peres S. Steyaert M-J. Bigan E. Paulevé L. Schwartz L. . (2015). Cell cycle progression is regulated by intertwined redox oscillators. Theor. Biol. Med. Model. 12:10. 10.1186/s12976-015-0005-226022743 De Korte C. L. Fekkes S. Nederveen A. J. Manniesing R. Hansen H. G. (2016). Review: Mechanical Characterization of Carotid Arteries and Atherosclerotic Plaques. IEEE Trans. Ultrason. Ferroelectr. Freq. Control. DeDuve C. (1991). Blueprint for a Cell: the Nature and Origin of Life, 1 edn, Burlington, NC: Carolina Biological Supply Co. Demetrius L. A. (2013). Boltzmann, darwin and directionality theory. Phys. Rep. 530, 1–85. 10.1016/j.physrep.2013.04.001 Demetrius L. A. Driver J. (2013). Alzheimer's as a metabolic disease. Biogerontology 14, 641–649. 10.1007/s10522-013-9479-724249045 Demetrius L. A. Coy J. F. Tuszynski J. A. (2010). Cancer proliferation and therapy: the Warburg effect and quantum metabolism. Theor. Biol. Med. Model. 7:2. 10.1186/1742-4682-7-220085650 Demetrius L. A. Magistretti P. J. Pellerin L. (2014). Alzheimer's disease: the amyloid hypothesis and the Inverse Warburg effect. Front. Physiol. 5:522. 10.3389/fphys.2014.0052225642192 Diamant N. E. (2006). Pathophysiology of Gastroesophageal Reflux Disease. GI Motil Online. 10.1038/gimo21 Douville N. J. Zamankhan P. Tung Y. C. Li R. Vaughan B. L. Takayama C. S. . (2011). Combination of fluid and solid mechanical stresses contribute to cell death and detachment in a microfluidic alveolar model. Lab. Chip 11, 609–619. 10.1039/C0LC00251H21152526 Eiken O. Kölegård R. Mekjavic I. B. (2008). Pressure-distension relationship in arteries and arterioles in response to 5 wk of horizontal bedrest. Am. J. Physiol. Heart Circ. Physiol. 295, H1296–H1302. 10.1152/ajpheart.00576.200818660441 Emery P. W. (2005). Metabolic changes in malnutrition. Eye Lond. Engl. 19, 1029–1034. 10.1038/sj.eye.670195916304580 Eyckmans J. Boudou T. Yu X. Chen C. S. (2011). A hitchhiker's guide to mechanobiology. Dev. Cell. 21, 35–47. 10.1016/j.devcel.2011.06.01521763607 Fang B. Wang D. Huang M. Yu G. Li H. (2010). Hypothesis on the relationship between the change in intracellular pH and incidence of sporadic Alzheimer's disease or vascular dementia. Int. J. Neurosci. 120, 591–595. 10.3109/00207454.2010.505353 Fermi E. (1956). Thermodynamics. New York, NY: Dover Publications. Fisher M. H. Amend A. M. Bach T. J. Barker J. M. Brady E. J. Candelore M. R. . (1998). A selective human β3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. J. Clin. Invest. 101, 2387–2393. 10.1172/JCI24969616210 Flammer J. Orgül S. Costa V. P. Orzalesi N. Krieglstein G. K. Serra L. M. . (2002). The impact of ocular blood flow in glaucoma. Prog. Retin. Eye Res. 21, 359–393. 10.1016/S1350-9462(02)00008-312150988 Fleury V. Schwartz L. (2003). Numerical investigation of the effect of loss of cellular polarity on cancer invasiveness and geometry. Fractals 11, 397–414. 10.1142/S0218348X0300204X Frankenfield D. C. Smith J. S. Cooney R. N. Blosser S. A. Sarson G. Y. (1997). Relative association of fever and injury with hypermetabolism in critically ill patients. Injury 28, 617–621. 10.1016/S0020-1383(97)00117-49624339 Gnudi L. Viberti G. Raij L. Rodriguez V. Burt D. Cortes P. . (2003). GLUT-1 overexpression: link between hemodynamic and metabolic factors in glomerular injury? Hypertension 42, 19–24. 10.1161/01.HYP.0000075949.19968.EF12771048 Goldman D. E. (1943). Potential, impedance and rectification in membranes. J. Gen. Physiol. 27, 37–60. 10.1085/jgp.27.1.3719873371 Goldman S. M. Tanner C. M. Oakes D. Bhudhikanok G. S. Gupta A. Langston J. W. (2006). Head injury and Parkinson's disease risk in twins. Ann. Neurol. 60, 65–72. 10.1002/ana.2088216718702 Gottlieb R. A. Nordberg J. Skowronski E. Babior B. M. (1996). Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc. Natl. Acad. Sci. U.S.A. 93, 654–658. 10.1073/pnas.93.2.6548570610 Green D. E. Young J. H. (1971). Energy transduction in membrane systems. Am. Sci. 59, 92–100. 5547538 Gregory D. E. Callaghan J. P. (2010). An examination of the influence of strain rate on subfailure mechanical properties of the annulus fibrosus. J. Biomech. Eng. 132:091010. 10.1115/1.400194520815644 Grimble R. F. (2003). Inflammatory response in the elderly. Curr. Opin. Clin. Nutr. Metab. Care 6, 21–29. 10.1097/00075197-200301000-0000512496677 Gudmundsson L. S. Thorgeirsson G. Sigfusson N. Sigvaldason H. Johannsson M. (2006). Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21,537 subjects. The Reykjavik Study. Cephalalgia Int. J. Headache 26, 436–444. 10.1111/j.1468-2982.2005.01057.x16556245 Gutmann L. Gutmann L. (1996). Axonal channelopathies: an evolving concept in the pathogenesis of peripheral nerve disorders. Neurology 47, 18–21. 10.1212/WNL.47.1.188710074 Joule J. P. (1843). On the Calorific Effects of Magneto-Electricity, and on the Mechanical Value of Heat. Avaliable online at: http://iom3.tandfonline.com/doi/abs/10.1080/14786444308644730?journalCode=tphm14 Hackenbrock C. R. (1968). Ultrastructural bases for metabolically linked mechanical activity in mitochondria ii. electron transport-linked ultrastructural transformations in mitochondria. J. Cell Biol. 37, 345–369. 10.1083/jcb.37.2.3455656397 Hamill O. P. Martinac B. (2001). Molecular basis of mechanotransduction in living cells. Physiol. Rev. 81, 685–740. 10.1152/physrev.2001.81.2.68511274342 Hand S. C. Carpenter J. F. (1986). pH-induced metabolic transitions in artemia embryos mediated by a novel hysteretic trehalase. Science 232, 1535–1537. 10.1126/science.232.4757.153517773504 Harris R. A. Penniston J. T. Asai J. Green D. E. (1968). The conformational basis of energy conservation in membrane systems. II. Correlation between conformational change and functional states. Proc. Natl. Acad. Sci. U.S.A. 59, 830–837. 10.1073/pnas.59.3.8305238663 Hasiloglu Z. I. Albayram S. Gorucu Y. Selcuk H. Cagil E. Erdemli H. E. . (2012). Assessment of CSF flow dynamics using PC-MRI in spontaneous intracranial hypotension. Headache 52, 808–819. 10.1111/j.1526-4610.2012.02150.x22512384 Henderson W. R. Sheel A. W. (2012). Pulmonary mechanics during mechanical ventilation. Respir. Physiol. Neurobiol. 180, 162–172. 10.1016/j.resp.2011.11.01422154694 Hirai K. Aliev G. Nunomura A. Fujioka H. Russell R. L. Atwood C. S. . (2001). Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21, 3017–3023. 11312286 Hodgkin A. L. Huxley A. F. (1952). A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 117, 500–544. 10.1113/jphysiol.1952.sp00476412991237 Holcman D. Yuste R. (2015). The new nanophysiology: regulation of ionic flow in neuronal subcompartments. Nat. Rev. Neurosci. 16, 685–692. 10.1038/nrn402226462753 Imray C. (2016). Lessons from altitude: cerebral perfusion insights and their potential clinical significance. Exp. Physiol. 101, 1167–1172. 10.1113/EP085813 Israël M. Schwartz L. (2011). The metabolic advantage of tumor cells. Mol. Cancer 10:70. 10.1186/1476-4598-10-7021649891 Jacobs C. R. Huang H. Kwon R. Y. (2012). Introduction to Cell Mechanics and Mechanobiology. New York, NY: Garland Science. Jay E.-L. Nestler S. Sierra M. McClelland J. Kekic M. David A. S. (2016). Ventrolateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of depersonalization disorder: a consecutive case series. Psychiatry Res. 240, 118–122. 10.1016/j.psychres.2016.04.02727104926 Jiang G. Solbrig H. R. Chute C. G. (2013). Using semantic Web technology to support icd-11 textual definitions authoring. J. Biomed. Semant. 4:11. 10.1186/2041-1480-4-1123601451 Johnson N. J. Luks A. M. (2016). High-altitude medicine. Med. Clin. North Am. 100, 357–369. 10.1016/j.mcna.2015.09.00226900119 Johnson V. E. Stewart W. Smith D. H. (2012). Widespread τ and amyloid-β pathology many years after a single traumatic brain injury in humans. Brain Pathol. Zurich Switz. 22, 142–149. 10.1111/j.1750-3639.2011.00513.x21714827 Katzung B. G. Masters S. B. Trevor A. J. (2015). Basic & Clinical Pharmacology, 13th edn. San Francisco, CA: McGraw-Hill Professional. Kim H.-D. Wong P. K. Park J. Levchenko A. Sun Y. (2009). Microengineered platforms for cell mechanobiology. Annu. Rev. Biomed. Eng. 11, 203–233. 10.1146/annurev-bioeng-061008-12491519400708 Kongstad L. Grände P. O. (1999). Local vascular response during organ elevation. A model for cerebral effects of upright position and dural puncture. Acta Anaesthesiol. Scand. 43. 438–446. 10.1034/j.1399-6576.1999.430412.x10225078 Kreimeier U. (2000). Pathophysiology of fluid imbalance. Crit. Care 4, S3–S7. 10.1186/cc96811255592 Kubota K. Yoshimura N. Yokota M. Fitzsimmons R. J. Wikesjö M. E. (1995). Overview of effects of electrical stimulation on osteogenesis and alveolar bone. J. Periodontol. 66, 2–6. 10.1902/jop.1995.66.1.27891245 Kumar R. Lozano A. M. Kim Y. J. Hutchison W. D. Sime E. Halket E. . (1998). Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 51, 850–855. 10.1212/WNL.51.3.8509748038 Kurdistani S. K. (2014). Chromatin: a capacitor of acetate for integrated regulation of gene expression and cell physiology. Curr. Opin. Genet. Dev. 26, 53–58. 10.1016/j.gde.2014.06.00225016437 Lane N. Martin W. F. (2012). The origin of membrane bioenergetics. Cell 151, 1406–1416. 10.1016/j.cell.2012.11.05023260134 Lee C. H. Cragoe E. J. Edwards A. M. (2003). Control of hepatocyte DNA synthesis by intracellular pH and its role in the action of tumor promoters. J. Cell. Physiol. 195, 61–69. 10.1002/jcp.1022512599209 Lehninger A. L. (1965). Bioenergetics: The Molecular Basis of Biological Energy Transformations. New York, NY: Benjamin/Cummings Pub. Lehninger A. L. (1971). Bioenergetics in Soft Cover - “Pursuit of Happiness” Books, W.A. Benjamin Publishing. Avaliable online at: http://www.abebooks.com/Bioenergetics-Albert-L-Lehninger-W.A-Benjamin/401866590/bd (Accessed May 1, 2016). Levine A. J. Puzio-Kuter A. M. (2010). The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330, 1340–1344. 10.1126/science.119349421127244 Levy Nogueira M. da Veiga Moreira J. Baronzio G. F. Dubois B-J. Steyaert M. Schwartz L. (2016). Mechanical Stress as the Common denominator between chronic inflammation, cancer, and Alzheimer's Disease. Front. Oncol. 5:197. 10.3389/fonc.2015.0019726442209 Levy Nogueira M. Epelbaum S. Steyaert J-M. Dubois B. Schwartz L. (2015a). Mechanical stress models of Alzheimer's disease pathology. Alzheimers Dement. J. Alzheimers Assoc. 12, 324–333. 10.1016/j.jalz.2015.10.00526718585 Levy Nogueira M. Lafitte O. Steyaert J-M. Bakardjian H. Dubois B. Schwartz L. . (2015b). Mechanical stress related to brain atrophy in Alzheimer's disease. Alzheimers Dement. 12, 11–20. 10.1016/j.jalz.2015.03.00526086185 Li Q. Huang H. Liu G. Lam K. Rutberg J. Green M. S. . (2009). Gain-of-function mutation of Nav1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing. Biochem. Biophys. Res. Commun. 380, 132–137. 10.1016/j.bbrc.2009.01.05219167345 Locke D. (1998). Gap junctions in normal and neoplastic mammary gland. J. Pathol. 186, 343–349. 10.1002/(SICI)1096-9896(199812)186:4<343::AID-PATH189>3.0.CO;2-X10209481 Loscalzo J. Kohane I. Barabasi A-L. (2007). Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol. Syst. Biol. 3:124. 10.1038/msb410016317625512 Louis E. D. (2014). Re-thinking the biology of essential tremor: from models to morphology. Parkinsonism Relat. Disord. 20(Suppl 1), S88–S93. 10.1016/S1353-8020(13)70023-324262197 Magnus-Levy A. (1895). Ueber den respiratorischen Gaswechsel unter Einfluss de Thyroidea sowie unter verschiedenen pathologische Zustand. Berlin Klin. Wochschr. 32, 650–652. McAninch E. A. Bianco A. C. (2016). The History and future of treatment of hypothyroidism. Ann. Intern. Med. 164, 50–56. 10.7326/M15-179926747302 McBrian M. A. Behbahan I. S. Ferrari R. Su T. Huang W-T. Kurdistani S. K. . (2013). Histone acetylation regulates intracellular pH. Mol. Cell. 49, 310–321. 10.1016/j.molcel.2012.10.02523201122 McKee A. C. Stern R. A. Nowinski C. J. Stein T. D. Alvarez V. E. Daneshvar D. H. . (2013). The spectrum of disease in chronic traumatic encephalopathy. Brain J. Neurol. 136, 43–64. 10.1093/brain/aws30723208308 Meinzer M. Lindenberg R. Darkow R. Ulm L. Copland D. Flöel A. (2014). Transcranial direct current stimulation and simultaneous functional magnetic resonance imaging. J. Vis. Exp. 86:e51730. 10.3791/51730 Mertens J. Wang Q-W. Kim Y. Yu D. X. Pham S. Yang B. . (2015). Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature 527, 95–99. 10.1038/nature1552626524527 Mirzaali M. J. Bürki A. Schwiedrzik J. Zysset P. K. Wolfram U. (2015). Continuum damage interactions between tension and compression in osteonal bone. J. Mech. Behav. Biomed. Mater. 49, 355–369. 10.1016/j.jmbbm.2015.05.00726093346 Modesto K. Sengupta P. P. (2014). Myocardial mechanics in cardiomyopathies. Prog. Cardiovasc. Dis. 57, 111–124. 10.1016/j.pcad.2014.03.00325081406 Montón C. Torres A. (1998). Lung inflammatory response in pneumonia. Monaldi Arch. Chest Dis. Arch. Monaldi Mal. Torace 53, 56–63. 9632909 Moolenaar W. H. Boonstra J. P. T. van der Saag de Laat S. W. (1981). Sodium/proton exchange in mouse neuroblastoma cells. J. Biol. Chem. 256, 12883–12887. 7309738 Moreira P. I. Siedlak S. L. Wang X. Santos M. S. Oliveira C. R. Tabaton M. . (2007). Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 3, 614–615. 10.4161/auto.487217786024 Moriyama I. M. Loy R. M. A. Robb-Smith H. T. Hoyert D. L. Rosenberg H. M. (2011). History of the Statistical Classification of Diseases and Causes of Death, U.S. Department of Health and Human Services; Centers for Disease Control and Prevention; National Center for Health Statistics. Nahorski S. R. Rogers K. J. (1973). In vivo effects of amphetamine on metabolites and metabolic rate in brain. J. Neurochem. 21, 679–686. 10.1111/j.1471-4159.1973.tb06012.x4742145 Narendra D. Tanaka A. Suen F.-D. Youle R. J. (2009). Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 5, 706–708. 10.4161/auto.5.5.850519377297 Neeland I. J. Drazner M. H. Berry J. D. Ayers C. R. deFilippi C. Seliger S. L. . (2013). Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. J. Am. Coll. Cardiol. 61, 187–195. 10.1016/j.jacc.2012.10.01223219305 Neviaser A. Andarawis-Puri N. Flatow E. (2012). Basic mechanisms of tendon fatigue damage. J. Shoulder Elbow. Surg. 21, 158–163. 10.1016/j.jse.2011.11.01422244058 Ni Z. Chen R. (2015). Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases. Transl. Neurodegener. 4:22. 10.1186/s40035-015-0045-x26579223 Nicholls D. G. Ferguson S. J. Ferguson S. (2002). Bioenergetics. 3rd edn, San Diego, CA: Academic Press. Numata S. Itatani K. Kanda K. Doi K. Yamazaki S. Morimoto K. . (2016). Blood flow analysis of the aortic arch using computational fluid dynamics. Eur. J. Cardio Thorac. Surg. 49, 1578–1585. 10.1093/ejcts/ezv45926792932 Orešković D. Klarica M. (2011). Development of hydrocephalus and classical hypothesis of cerebrospinal fluid hydrodynamics: facts and illusions. Prog. Neurobiol. 94, 238–258. 10.1016/j.pneurobio.2011.05.00521641963 Pandolfino J. E. Kwiatek M. A. Ho K. Scherer J. R. Kahrilas P. J. (2010). Unique features of esophagogastric junction pressure topography in hiatus hernia patients with dysphagia. Surgery 147, 57–64. 10.1016/j.surg.2009.05.01119744454 Pasteur (1881). On the germ theory. Science 2, 420–422. Pethig R. Kell D. B. (1987). The passive electrical properties of biological systems: their significance in physiology, biophysics and biotechnology. Phys. Med. Biol. 32:933. 10.1088/0031-9155/32/8/0013306721 Petrov A. G. (2002). Flexoelectricity of model and living membranes. Biochim. Biophys. Acta 1561, 1–25. 10.1016/S0304-4157(01)00007-711988178 Petrov A. G. (2006). Electricity and mechanics of biomembrane systems: flexoelectricity in living membranes. Anal. Chim. Acta 568, 70–83. 10.1016/j.aca.2006.01.10817761248 Picano E. Pellikka P. A. (2016). Ultrasound of extravascular lung water: a new standard for pulmonary congestion. Eur. Heart J. 37, 2097–2104. 10.1093/eurheartj/ehw16427174289 Plassman B. L. Havlik R. J. Steffens D. C. Helms M. J. Newman T. N. Drosdick D. . (2000). Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 55, 1158–1166. 10.1212/WNL.55.8.115811071494 Pokorný J. Pokorný J. Kobilková J. Jandová A. Vrba J. Vrba J. (2014). Targeting mitochondria for cancer treatment - two types of mitochondrial dysfunction. Prague Med. Rep. 115, 104–119. 10.14712/23362936.2014.4125626329 Porporato P. E. Dhup S. Dadhich R. K. Copetti T. Sonveaux P. (2011). Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front. Pharmacol. 2:49. 10.3389/fphar.2011.0004921904528 Porter C. Herndon D. N. Børsheim E. Chao T. Reidy P. T. Borack M. S. . (2014). Uncoupled skeletal muscle mitochondria contribute to hypermetabolism in severely burned adults. Am. J. Physiol. Endocrinol. Metab. 307, E462–E467. 10.1152/ajpendo.00206.201425074988 Preston D. C. Shapiro B. E. (2012). Electromyography and Neuromuscular Disorders: Clinical-Electrophysiologic Correlations (Expert Consult - Online), Shanghai: Elsevier Health Sciences 2012. Pupillo E. Messina P. Logroscino G. Zoccolella S. Chiò A. Calvo A. . (2012). EURALS consortium, trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. Eur. J. Neurol. Soc. 19, 1509–1517. 10.1111/j.1468-1331.2012.03723.x Puwanant S. Park M. Popović Z. B. W. Tang H. W. Farha S. Thomas J. D. . (2010). Ventricular geometry, strain, and rotational mechanics in pulmonary hypertension. Circulation 121, 259–266. 10.1161/CIRCULATIONAHA.108.84434020048214 Ratheiser K. M. Brillon D. J. Campbell R. G. Matthews D. E. (1998). Epinephrine produces a prolonged elevation in metabolic rate in humans. Am. J. Clin. Nutr. 68, 1046–1052. 10.1093/ajcn/68.5.10469808221 Reynolds E. (2001). Todd, Hughlings Jackson, and the electrical basis of epilepsy. Lancet Lond. Engl. 358, 575–577. 10.1016/S0140-6736(01)05710-511520547 Robicsek F. Thubrikar M. J. (2002). Mechanical stress as cause of aortic valve disease. Presentation of a new aortic root prosthesis. Acta Chir. Belg. 102, 1–6. 10.1080/00015458.2002.1167925311925731 Rumsey W. L. Pawlowski M. Lejavardi N. Wilson D. F. (1994). Oxygen pressure distribution in the heart in vivo and evaluation of the ischemic “border zone”. Am. J. Physiol. 266, H1676–H1680. 8184947 Runyon B. A. (1994). Malignancy-related ascites and ascitic fluid “humoral tests of malignancy. J. Clin. Gastroenterol. 18, 94–98. 10.1097/00004836-199403000-000028189030 Safar M. E. Levy B. I. Struijker-Boudier H. (2003). Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107, 2864–2869. 10.1161/01.CIR.0000069826.36125.B412796414 Safar M. E. Nilsson P. M. Blacher J. Mimran A. (2012). Pulse pressure, arterial stiffness, and end-organ damage. Curr. Hypertens. Rep. 14, 339–344. 10.1007/s11906-012-0272-922555981 Saji N. Toba K. Sakurai T. (2016). Cerebral small vessel disease and arterial stiffness: tsunami effect in the brain? Pulse Basel Switz, 3, 182–189. 10.1159/00044361427195239 Sardet C. Franchi A. Pouysségur J. (1989). Molecular cloning, primary structure, and expression of the human growth factor-activatable Na+/H+ antiporter. Cell 56, 271–280. 10.1016/0092-8674(89)90901-X2536298 Schilli R. Breuer R. I. Klein F. Dunn K. Gnaedinger A. Bernstein J. . (1982). Comparison of the composition of faecal fluid in Crohn's disease and ulcerative colitis. Gut 23, 326–332. 10.1136/gut.23.4.3267076010 Schmidt M. L. Zhukareva V. Newell K. L. Lee V. M. Trojanowski J. Q. (2001). Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol. 101, 518–524. 10.1007/s00401000033011484824 Schwartz L. (2004). Cancer - Between Glycolysis and Physical Constraint: Between Glycolysis and Physical Constraint. Springer Science & Business Media. Schwartz L. (2014). Is liver disease caused by increased pressure? interstitial pressure as a causative mechanism in carcinogenesis and in the differential blood supply in liver tumors from the hepatic artery. J. Liver. 3:156. 10.4172/2167-0889.1000156 Schwartz L. Abolhassani M. Guais A. Sanders E. J. Steyaert M. Israël M. . (2010). A combination of α lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results. Oncol. Rep. 23, 1407–1416. 10.3892/or_0000077820372858 Schwartz L. Abolhassani M. Pooya M. Steyaert J-M. Wertz X. Chaumet-Riffaud P. . (2008). Hyperosmotic stress contributes to mouse colonic inflammation through the methylation of protein phosphatase 2A. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G934–G941. 10.1152/ajpgi.90296.200818755808 Schwartz L. Balosso J. Baillet F. Brun B. Amman J. P. Sasco A. J. (2002). Cancer: the role of extracellular disease. Med. Hypotheses 58, 340–346. 10.1054/mehy.2001.153912027530 Schwartz L. Guais A. Pooya M. Abolhassani M. (2009). Is inflammation a consequence of extracellular hyperosmolarity? J. Inflamm. Lond. Engl. 6:21. 10.1186/1476-9255-6-2119549308 Schwartz L. Supuran C. T. Alfarouk K. O. (2017). The Warburg effect and the hallmarks of cancer. Anti Cancer Agents Med. Chem 17, 164–170. 10.2174/187152061666616103114330127804847 Seyfried T. N. Shelton L. M. (2010). Cancer as a metabolic disease. Nutr. Metab. 7:7. 10.1186/1743-7075-7-720181022 Sheean G. L. (2012). Quantification of motor unit action potential energy, Clin. Neurophysiol. 123, 621–625. 10.1016/j.clinph.2011.08.00921903464 Shoham N. Gefen A. (2012). Deformations, mechanical strains and stresses across the different hierarchical scales in weight-bearing soft tissues. J. Tissue Viability 21, 39–46. 10.1016/j.jtv.2012.03.00122520396 Silver F. H. Bradica G. (2002). Mechanobiology of cartilage: how do internal and external stresses affect mechanochemical transduction and elastic energy storage? Biomech. Model. Mechanobiol. 1, 219–238. 10.1007/s10237-002-0017-914586701 Singhal A. Parker S. Linsell L. Serjeant G. (2002). Energy intake and resting metabolic rate in preschool Jamaican children with homozygous sickle cell disease. Am. J. Clin. Nutr. 75, 1093–1097. 10.1093/ajcn/75.6.109312036818 Sipe J. D. (1995). Acute-phase proteins in osteoarthritis. Semin. Arthritis Rheum. 25, 75–86. 10.1016/S0049-0172(95)80020-48578314 Song W. Xiao Y. Chen H. Ashpole N. M. Piekarz A. D. Ma P. . (2012). The human Nav1.5 F1486 deletion associated with long QT syndrome leads to impaired sodium channel inactivation and reduced lidocaine sensitivity. J. Physiol. 590, 5123–5139. 10.1113/jphysiol.2012.23537422826127 Srivastava A. Mannam P. (2015). Warburg revisited: lessons for innate immunity and sepsis. Front. Physiol. 6:70. 10.3389/fphys.2015.0007025806001 Staples J. F. (2016). Metabolic flexibility: hibernation, torpor, and estivation. Compr. Physiol. 6, 737–771. 10.1002/cphy.c14006427065167 Stein T. D. Alvarez V. E. McKee A. C. (2014). Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel. Alzheimers Res. Ther. 6:4. 10.1186/alzrt23424423082 Streitberger J.-K. Wiener E. Hoffmann J. Freimann F. B. Klatt D. Braun J. . (2011). In vivo viscoelastic properties of the brain in normal pressure hydrocephalus. NMR Biomed. 24, 385–392. 10.1002/nbm.160220931563 Stuart G. Spruston N. Häusser M. (2016). Dendrites. Oxford: Oxford University Press. Sun P. Qin J. Campbell K. (2015). Fatigue modeling via mammalian auditory system for prediction of noise induced hearing loss. Comput. Math. Methods Med. 2015:753864. 10.1155/2015/75386426691685 Swenson E. R. Maggiorini M. Mongovin S. J. Gibbs S. R. Greve I. Bärtsch P. . (2002). Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 287, 2228–2235. 10.1001/jama.287.17.2228 Szturmowicz M. Tomkowski W. Fijalkowska A. Burakowski J. Sakowicz A. Filipecki S. (1997). The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis. Int. J. Biol. Markers 12, 96–101. 9479590 Thakral G. Lafontaine J. Najafi B. Talal T. K. Kim P. Lavery L. A. (2013). Electrical stimulation to accelerate wound healing. Diabet. Foot Ankle. 4. 10.3402/dfa.v4i0.2208124049559 Theuvenet P. J. Dunajski Z. Peters M. J. van Ree J. M. (1999). Responses to median and tibial nerve stimulation in patients with chronic neuropathic pain, Brain Topogr. 11, 305–313. 10.1023/A:1022210704505 Thompson D. W. (1942). On Growth and Form. Cambridge: Cambridge University Press. Uryu K. Chen X-H. Martinez D. Browne K. D. Johnson V. E. Smith D. H. . (2007). Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp. Neurol. 208, 185–192. 10.1016/j.expneurol.2007.06.01817826768 Valdez M. Balachandran B. (2013). Longitudinal nonlinear wave propagation through soft tissue. J. Mech. Behav. Biomed. Mater. 20, 192–208. 10.1016/j.jmbbm.2013.01.00223510921 van Alphen H. A. (1986). Migraine, a result of increased CSF pressure: a new pathophysiological concept (preliminary report). Neurosurg. Rev. 9, 121–124. 10.1007/BF017430623736895 Villafuerte F. C. Corante N. (2016). Chronic mountain sickness: clinical aspects, etiology, management, and treatment. High Alt. Med. Biol. 17, 61–69. 10.1089/ham.2016.003127218284 Vincent K. R. Conrad B. P. Fregly B. J. Vincent H. K. (2012). The pathophysiology of osteoarthritis: a mechanical perspective on the knee joint, PM R. 4, S3–S9. 10.1016/j.pmrj.2012.01.02022632700 Visser A. W. de Mutsert R. le Cessie S. den Heijer M. Rosendaal F. R. Kloppenburg M. (2014). The relative contribution of mechanical stress and systemic processes in different types of osteoarthritis: the NEO study. Ann. Rheum. Dis. 74, 1842–1877. 10.1136/annrheumdis-2014-eular.317924845389 Warburg O. (1956). On the origin of cancer cells. Science 123, 309–314. 10.1126/science.123.3191.30913298683 Wiener T. C. (2012). Space obstructive syndrome: intracranial hypertension, intraocular pressure, and papilledema in space. Aviat. Space Environ. Med. 83, 64–66. 10.3357/ASEM.3083.201222272520 Wilson M. H. Imray H. E. Hargens A. R. (2011). The headache of high altitude and microgravity–similarities with clinical syndromes of cerebral venous hypertension. High Alt. Med. Biol. 12, 379–386. 10.1089/ham.2011.102622087727 Yakushev I. Gerhard A. Müller M. J. Lorscheider M. Buchholz G.-H. Schermuly I. . (2011). Relationships between hippocampal microstructure, metabolism, and function in early Alzheimer's disease. Brain Struct. Funct. 216, 219–226. 10.1007/s00429-011-0302-421318476 Zetterberg A. Engström W. (1981). Mitogenic effect of alkaline pH on quiescent, serum-starved cells. Proc. Natl. Acad. Sci. U.S.A. 78, 4334–4338. 10.1073/pnas.78.7.43346945587 Zhang P. C. Keleshian A. M. Sachs F. (2001). Voltage-induced membrane movement. Nature 413, 428–432. 10.1038/3509657811574890 Zhang Z. Tang S. Zhu L. Wu G. Jiang Z. Shi B. (2008). [Stresses in portal venous system of pre-hepatic portal hypertension (PHT) rabbits], Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. J. Biomed. Eng. Shengwu Yixue Gongchengxue Zazhi. 25, 1322–1326.